Skip to main content

Advertisement

SpringerLink
Log in

Vaccination against Human Papilloma Virus (HPV): Epidemiological Evidence of HPV in Non-genital Cancers

  • Published:
Pathology & Oncology Research

Abstract

Recently, the vaccine against human papillomavirus (HPV) was introduced in the national vaccination programmes of several countries worldwide. The established association between HPV and the progression of cervical neoplasia provides evidence of the expected protection of the vaccine against cervical cancer. During the last two decades several studies have also examined the possible involvement of HPV in non-genital cancers and have proposed the presence of HPV in oesophageal, laryngeal, oropharyngeal, lung, urothelial, breast and colon cancers. The possible involvement of HPV in these types of cancer would necessitate the introduction of the vaccine in both boys and girls. However, the role of HPV in the pathogenesis of these types of cancer has yet to be proven. Moreover, the controversial evidence of the possible impact of the vaccination against HPV in the prevention of non-genital cancers needs to be further evaluated. In this review, we present an overview of the existing epidemiological evidence regarding the detection of HPV in non-genital cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342–350

    Article  PubMed  CAS  Google Scholar 

  2. Sanclemente G, Gill DK (2002) Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol 16:231–240

    Article  PubMed  CAS  Google Scholar 

  3. Peto J, Gilham C, Deacon J et al (2004) Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 91:942–953

    PubMed  CAS  Google Scholar 

  4. Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527

    Article  PubMed  Google Scholar 

  5. Clifford GM, Smith JS, Plummer M et al (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:63–73

    Article  PubMed  CAS  Google Scholar 

  6. Fehrmann F, Laimins LA (2003) Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22:5201–5207

    Article  PubMed  CAS  Google Scholar 

  7. Mammas I, Sourvinos G, Giannoudis A, Spandidos DA (2008) Human papilloma virus (HPV) and host cellular interactions. Pathol Oncol Res 14:345–354

    Article  PubMed  CAS  Google Scholar 

  8. Zaravinos A, Mammas I, Sourvinos G, Spandidos DA (2009) Detection methods of human papilloma virus (HPV). Int J Biol Markers 24(24):215–222

    Google Scholar 

  9. Syrjänen KJ (2002) HPV infections and oesophageal cancer. J Clin Pathol 55:721–728

    Article  PubMed  Google Scholar 

  10. Sur M, Cooper K (1998) The role of the human papilloma virus in esophageal cancer. Pathology 30:348–354

    Article  PubMed  CAS  Google Scholar 

  11. Bohn OL, Navarro L, Saldivar J, Sanchez-Sosa S (2008) Identification of human papillomavirus in esophageal squamous papillomas. World J Gastroenterol 14:7107–7111

    Article  PubMed  Google Scholar 

  12. van Zeeburg HJ, Snijders PJ, Wu T et al (2008) Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 100:1649–1653

    Article  PubMed  CAS  Google Scholar 

  13. Rai N, Jenkins GJ, McAdam E et al (2008) Human papillomavirus infection in Barrett’s oesophagus in the UK: an infrequent event. J Clin Virol 43:250–252

    Article  PubMed  CAS  Google Scholar 

  14. Bognar G, Imdahl A, Ledniczky G, Ondrejka P (2008) Possible role of human papilloma virus infection in response to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterology 55:93–97

    PubMed  Google Scholar 

  15. Koh JS, Lee SS, Baek HJ, Kim YI (2008) No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction. Dis Esophagus 21:114–117

    Article  PubMed  CAS  Google Scholar 

  16. Lu XM, Monnier-Benoit S, Mo LZ, Xu SY et al (2008) Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol 34:765–770

    Article  PubMed  CAS  Google Scholar 

  17. Matsha T, Donninger H, Erasmus RT et al (2007) Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas. Virology 369:182–190

    Article  PubMed  CAS  Google Scholar 

  18. Shuyama K, Castillo A, Aguayo F et al (2007) Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 96:1554–1559

    Article  PubMed  CAS  Google Scholar 

  19. Pantelis A, Pantelis D, Ruemmele P et al (2007) p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. Oncol Rep 17:1243–1248

    PubMed  CAS  Google Scholar 

  20. Far AE, Aghakhani A, Hamkar R et al (2007) Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand J Infect Dis 39:58–62

    Article  PubMed  Google Scholar 

  21. Qi ZL, Huo X, Xu XJ et al (2006) Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. Exp Oncol 28:235–240

    PubMed  CAS  Google Scholar 

  22. Castillo A, Aguayo F, Koriyama C et al (2006) Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol 12:6188–6192

    PubMed  Google Scholar 

  23. Souto Damin AP, Guedes Frazzon AP, de Carvalho DD et al (2006) Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Dis Esophagus 19:64–68

    Article  PubMed  CAS  Google Scholar 

  24. Dreilich M, Bergqvist M, Moberg M et al (2006) High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer 6:94

    Article  PubMed  CAS  Google Scholar 

  25. Gao GF, Roth MJ, Wei WQ et al (2006) No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer 119:1354–1359

    Article  PubMed  CAS  Google Scholar 

  26. Lyronis ID, Baritaki S, Bizakis I et al (2005) Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 20:5–10

    PubMed  CAS  Google Scholar 

  27. White RE, Mungatana C, Mutuma G et al (2005) Absence of human papillomavirus in esophageal carcinomas from southwestern Kenya. Dis Esophagus 18:28–30

    Article  PubMed  CAS  Google Scholar 

  28. Farhadi M, Tahmasebi Z, Merat S et al (2005) Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 11:1200–1203

    PubMed  Google Scholar 

  29. Bahnassy AA, Zekri AR, Abdallah S et al (2005) Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int 55:53–62

    Article  PubMed  CAS  Google Scholar 

  30. Katiyar S, Hedau S, Jain N et al (2005) p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 218:69–79

    Article  PubMed  CAS  Google Scholar 

  31. Lu XM, Zhang YM, Lin RY et al (2004) p53 polymorphism in human papillomavirus-associated Kazakh’s esophageal cancer in Xinjiang, China. World J Gastroenterol 10:2775–2778

    PubMed  CAS  Google Scholar 

  32. Acevedo-Nuño E, González-Ojeda A, Vázquez-Camacho G et al (2004) Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett’s oesophagus and oesophagitis. Anticancer Res 24:1319–1323

    PubMed  Google Scholar 

  33. de Villiers EM, Gunst K, Stein H, Scherübl H (2004) Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences. Int J Cancer 109:253–258

    Article  PubMed  CAS  Google Scholar 

  34. Weston AC, Prolla JC (2003) Association between esophageal squamous cell carcinoma and human papillomavirus detected by Hybrid Capture II assay. Dis Esophagus 16:224–228

    Article  PubMed  CAS  Google Scholar 

  35. Kamath AM, Wu TT, Heitmiller R et al (2000) Investigation of the association of esophageal carcinoma with human papillomaviruses. Dis Esophagus 13:122–124

    Article  PubMed  CAS  Google Scholar 

  36. Awerkiew S, Bollschweiler E, Metzger R et al (2003) Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol 192:137–140

    Article  PubMed  CAS  Google Scholar 

  37. Zhou XB, Guo M, Quan LP et al (2003) Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 9:1170–1173

    PubMed  Google Scholar 

  38. Li T, Lu ZM, Guo M et al (2002) p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 95:2571–2576

    Article  PubMed  CAS  Google Scholar 

  39. Shen ZY, Hu SP, Lu LC et al (2002) Detection of human papillomavirus in esophageal carcinoma. J Med Virol 68:412–416

    Article  PubMed  Google Scholar 

  40. Hasegawa M, Ohoka I, Yamazaki K et al (2002) Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 52:442–450

    Article  PubMed  CAS  Google Scholar 

  41. Matsha T, Erasmus R, Kafuko AB et al (2002) Human papillomavirus associated with oesophageal cancer. J Clin Pathol 55:587–590

    Article  PubMed  CAS  Google Scholar 

  42. Astori G, Merluzzi S, Arzese A et al (2001) Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Digestion 64:9–14

    Article  PubMed  CAS  Google Scholar 

  43. Chang F, Syrjänen S, Shen Q et al (2000) Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Res 20:3935–3940

    PubMed  CAS  Google Scholar 

  44. Lambot MA, Haot J, Peny MO et al (2000) Evaluation of the role of human papillomavirus in oesophageal squamous cell carcinoma in Belgium. Acta Gastroenterol Belg 63:154–156

    PubMed  CAS  Google Scholar 

  45. Talamini G, Capelli P, Zamboni G et al (2000) Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer 86:874–878

    Article  PubMed  CAS  Google Scholar 

  46. Chang F, Syrjänen S, Shen Q et al (2000) Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization. Scand J Gastroenterol 35:123–130

    Article  PubMed  CAS  Google Scholar 

  47. de Villiers EM, Lavergne D, Chang F et al (1999) An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer 81:225–228

    Article  PubMed  Google Scholar 

  48. Lavergne D, de Villiers EM (1999) Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 80:681–684

    Article  PubMed  CAS  Google Scholar 

  49. Takahashi A, Ogoshi S, Ono H, Ishikawa T et al (1998) High-risk human papillomavirus infection and overexpression of p53 protein in squamous cell carcinoma of the esophagus from Japan. Dis Esophagus 11:162–167

    PubMed  CAS  Google Scholar 

  50. Khurshid A, Kazuya N, Hanae I, Manabu I (1998) Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. J Pak Med Assoc 48:138–142

    PubMed  CAS  Google Scholar 

  51. Morgan RJ, Perry AC, Newcomb PV et al (1997) Human papillomavirus and oesophageal squamous cell carcinoma in the UK. Eur J Surg Oncol 23:513–517

    Article  PubMed  CAS  Google Scholar 

  52. Kok TC, Nooter K, Tjong-A-Hung SP et al (1997) No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study Group. Eur J Cancer 33:1865–1868

    Article  PubMed  CAS  Google Scholar 

  53. He D, Zhang DK, Lam KY et al (1997) Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 72:959–964

    Article  PubMed  CAS  Google Scholar 

  54. Lam KY, He D, Ma L et al (1997) Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum Pathol 28:657–663

    Article  PubMed  CAS  Google Scholar 

  55. Miller BA, Davidson M, Myerson D et al (1997) Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska Natives. Int J Cancer 71:222

    Article  Google Scholar 

  56. Saegusa M, Hashimura M, Takano Y et al (1997) Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan. Mol Pathol 50:101–104

    Article  PubMed  CAS  Google Scholar 

  57. Mizobuchi S, Sakamoto H, Tachimori Y et al (1997) Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. Jpn J Clin Oncol 27:1–5

    Article  PubMed  CAS  Google Scholar 

  58. Morgan RJ, Perry AC, Newcomb PV et al (1997) Investigation of oesophageal adenocarcinoma for viral genomic sequences. Eur J Surg Oncol 23:24–29

    Article  PubMed  CAS  Google Scholar 

  59. Turner JR, Shen LH, Crum CP et al (1997) Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 28:174–178

    Article  PubMed  CAS  Google Scholar 

  60. Chang F, Syrjänen S, Wang L et al (1997) p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China. Anticancer Res 17:709–715

    PubMed  CAS  Google Scholar 

  61. Suzuk L, Noffsinger AE, Hui YZ, Fenoglio-Preiser CM (1996) Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer 78:704–710

    Article  PubMed  CAS  Google Scholar 

  62. Shibagaki I, Tanaka H, Shimada Y et al (1995) p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clin Cancer Res 1:769–773

    PubMed  CAS  Google Scholar 

  63. Smits HL, Tjong-A-Hung SP, ter Schegget J et al (1995) Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol 46:213–215

    Article  PubMed  CAS  Google Scholar 

  64. Cooper K, Taylor L, Govind S (1995) Human papillomavirus DNA in oesophageal carcinomas in South Africa. J Pathol 175:273–277

    Article  PubMed  CAS  Google Scholar 

  65. Chen B, Yin H, Dhurandhar N (1994) (1994) Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers. Hum Pathol 25:920–923

    Article  PubMed  CAS  Google Scholar 

  66. Si HX, Tsao SW, Poon CS et al (2005) Physical status of HPV-16 in esophageal squamous cell carcinoma. J Clin Virol 32:19–23

    Article  PubMed  CAS  Google Scholar 

  67. Yao PF, Li GC, Li J et al (2006) Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma. World J Gastroenterol 12:1352–1355

    PubMed  Google Scholar 

  68. Sugár J, Vereczkey I, Tóth J (1996) Some etio-pathogenetic factors in laryngeal carcinogenesis. J Environ Pathol Toxicol Oncol 15:195–199

    PubMed  Google Scholar 

  69. Baumann JL, Cohen S, Evjen AN et al (2009) Human papillomavirus in early laryngeal carcinoma. Laryngoscope 119:1531–1537

    Article  PubMed  Google Scholar 

  70. Morshed K, Polz-Dacewicz M, Szymański M, Polz D (2008) Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol 265:S89–S96

    Article  PubMed  Google Scholar 

  71. Szládek G, Juhász A, Kardos G et al (2005) High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma. J Clin Pathol 58:402–405

    Article  PubMed  Google Scholar 

  72. Almadori G, Cadoni G, Cattani P et al (2001) Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res 7:3988–3993

    PubMed  CAS  Google Scholar 

  73. Smith EM, Summersgill KF, Allen J et al (2000) Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol 109:1069–1076

    PubMed  CAS  Google Scholar 

  74. Lindeberg H, Krogdahl A (1999) Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 146:9–13

    Article  PubMed  CAS  Google Scholar 

  75. Cerovac Z, Sarcević B, Kralj Z, Ban J (1996) Detection of human papillomavirus (HPV) type 6, 16 and 18 in head and neck squamous cell carcinomas by in situ hybridization. Neoplasma 43:185–194

    PubMed  CAS  Google Scholar 

  76. Clayman GL, Stewart MG, Weber RS et al (1994) Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg 120:743–748

    PubMed  CAS  Google Scholar 

  77. Wang H, Lin YC, Kang XS et al (1991) Detection of human papilloma virus (HPV) in laryngeal carcinoma tissue. Chin Med J (Engl) 104:523–525

    CAS  Google Scholar 

  78. Reidy PM, Dedo HH, Rabah R et al (2004) Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 114:1906–1909

    Article  PubMed  Google Scholar 

  79. Turazza E, Lapeña A, Sprovieri O et al (1997) Low-risk human papillomavirus types 6 and 11 associated with carcinomas of the genital and upper aero-digestive tract. Acta Obstet Gynecol Scand 76:271–276

    PubMed  CAS  Google Scholar 

  80. Lee LA, Cheng AJ, Fang TJ et al (2008) High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope 118:50–55

    Article  PubMed  Google Scholar 

  81. Syrjänen S (2004) HPV infections and tonsillar carcinoma. J Clin Pathol 57:449–455

    Article  PubMed  Google Scholar 

  82. Näsman A, Attner P, Hammarstedt L et al (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362–366

    Article  PubMed  CAS  Google Scholar 

  83. Romanitan M, Näsman A, Ramqvist T et al (2008) Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Anticancer Res 28:2077–2080

    PubMed  Google Scholar 

  84. Hafkamp HC, Manni JJ, Haesevoets A et al (2008) Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 122:2656–2664

    Article  PubMed  CAS  Google Scholar 

  85. Kuo KT, Hsiao CH, Lin CH et al (2008) The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol 21:376–386

    Article  PubMed  CAS  Google Scholar 

  86. Westra WH, Taube JM, Poeta ML et al (2008) Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 14:366–369

    Article  PubMed  CAS  Google Scholar 

  87. Charfi L, Jouffroy T, de Cremoux P et al (2008) Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett 260:72–78

    Article  PubMed  CAS  Google Scholar 

  88. Pintos J, Black MJ, Sadeghi N et al (2008) Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol 44:242–250

    Article  PubMed  Google Scholar 

  89. Li W, Tran N, Lee SC et al (2007) New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology 39:217–222

    Article  PubMed  CAS  Google Scholar 

  90. Chien CY, Su CY, Fang FM et al (2008) Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol 44:174–179

    Article  PubMed  CAS  Google Scholar 

  91. Mellin Dahlstrand H, Lindquist D, Björnestål L et al (2005) P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 25:4375–4383

    PubMed  Google Scholar 

  92. Begum S, Cao D, Gillison M et al (2005) Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11:5694–5699

    Article  PubMed  CAS  Google Scholar 

  93. Hoffmann M, Gottschlich S, Görögh T et al (2005) Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Otolaryngol 125:415–421

    PubMed  Google Scholar 

  94. Venuti A, Badaracco G, Rizzo C et al (2004) Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res 23:561–566

    PubMed  CAS  Google Scholar 

  95. Azzimonti B, Pagano M, Mondini M et al (2004) Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology 45:560–572

    Article  PubMed  CAS  Google Scholar 

  96. Li W, Thompson CH, Cossart YE et al (2004) The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 26:1–9

    Article  PubMed  Google Scholar 

  97. El-Mofty SK, Lu DW (2003) Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 27:1463–1470

    Article  PubMed  Google Scholar 

  98. Hafkamp HC, Speel EJ, Haesevoets A et al (2003) A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8. Int J Cancer 107:394–400

    Article  PubMed  CAS  Google Scholar 

  99. Mellin H, Friesland S, Auer G et al (2003) Human papillomavirus and DNA ploidy in tonsillar cancer–correlation to prognosis. Anticancer Res 23:2821–2828

    PubMed  Google Scholar 

  100. Koskinen WJ, Chen RW, Leivo I et al (2003) Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107:401–406

    Article  PubMed  CAS  Google Scholar 

  101. Ryerson AB, Peters ES, Coughlin SS et al (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 113:2901–2909

    Article  PubMed  Google Scholar 

  102. Dahlstrand H, Näsman A, Romanitan M et al (2008) Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 28:1133–1138

    PubMed  Google Scholar 

  103. Kim SH, Koo BS, Kang S et al (2007) HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 120:1418–1425

    Article  PubMed  CAS  Google Scholar 

  104. Fischer CA, Zlobec I, Green E et al (2010) Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer 126:1256–1262

    PubMed  CAS  Google Scholar 

  105. Cohen MA, Basha SR, Reichenbach DK et al (2008) Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients. Acta Otolaryngol 128:583–589

    Article  PubMed  CAS  Google Scholar 

  106. D’Souza G, Agrawal Y, Halpem J et al (2009) Oral sexual behaviours associated with prevalent oral human papillomavirus infection. J Infect Dis 199:1263–1269

    Article  PubMed  Google Scholar 

  107. Mammas IN, Sourvinos G, Spandidos DA (2009) Human papilloma virus (HPV) infection in children and adolescents. Eur J Pediatr 168:267–273

    Article  PubMed  Google Scholar 

  108. Chen YC, Chen JH, Richard K et al (2004) Lung adenocarcinoma and human papillomavirus infection. Cancer 101:1428–1436

    Article  PubMed  Google Scholar 

  109. Syrjänen KJ (2002) HPV infections and lung cancer. J Clin Pathol 55:885–891

    Article  PubMed  Google Scholar 

  110. Yu Y, Yang A, Hu S, Yan H (2009) Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol Rep 21:1627–1632

    PubMed  CAS  Google Scholar 

  111. Castillo A, Aguayo F, Koriyama C et al (2006) Human papillomavirus in lung carcinomas among three Latin American countries. Oncol Rep 15:883–888

    PubMed  Google Scholar 

  112. Wang Y, Wang A, Jiang R et al (2008) Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep 20:333–339

    PubMed  CAS  Google Scholar 

  113. Aguayo F, Castillo A, Koriyama C et al (2007) Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 97:85–91

    Article  PubMed  CAS  Google Scholar 

  114. Giuliani L, Jaxmar T, Casadio C et al (2007) Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 57:273–281

    Article  PubMed  Google Scholar 

  115. Park MS, Chang YS, Shin JH et al (2007) The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J 48:69–77

    Article  PubMed  CAS  Google Scholar 

  116. Nadji SA, Mokhtari-Azad T, Mahmoodi M et al (2007) Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett 248:41–46

    Article  PubMed  CAS  Google Scholar 

  117. Ciotti M, Giuliani L, Ambrogi V et al (2006) Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep 16:183–189

    PubMed  CAS  Google Scholar 

  118. Jain N, Singh V, Hedau S et al (2005) Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128:3999–4007

    Article  PubMed  CAS  Google Scholar 

  119. Coissard CJ, Besson G, Polette MC et al (2005) Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 18:1606–1609

    PubMed  Google Scholar 

  120. Brouchet L, Valmary S, Dahan M et al (2005) Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 92:743–746

    Article  PubMed  CAS  Google Scholar 

  121. Zafer E, Ergun MA, Alver G et al (2004) Detection and typing of human papillomavirus in non-small cell lung cancer. Respiration 71:88–90

    Article  PubMed  Google Scholar 

  122. Fei Y, Yang J, Hsieh WC et al (2006) Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol 36:274–279

    Article  PubMed  Google Scholar 

  123. Miasko A, Niklińska W, Nikliński J et al (2001) Detection of human papillomavirus in non-small cell lung carcinoma by polymerase chain reaction. Folia Histochem Cytobiol 39:127–128

    PubMed  CAS  Google Scholar 

  124. Miyagi J, Kinjo T, Tsuhako K et al (2001) Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology 38:355–367

    Article  PubMed  CAS  Google Scholar 

  125. Kaya H, Kotiloğlu E, Inanli S et al (2001) Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 93:531–534

    PubMed  CAS  Google Scholar 

  126. Cheng YW, Chiou HL, Sheu GT et al (2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61:2799–2803

    PubMed  CAS  Google Scholar 

  127. Gorgoulis VG, Zacharatos P, Kotsinas A et al (1999) Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30:274–283

    Article  PubMed  CAS  Google Scholar 

  128. Tsuhako K, Nakazato I, Hirayasu T et al (1998) Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 51:741–749

    Article  PubMed  CAS  Google Scholar 

  129. Papadopoulou K, Labropoulou V, Davaris P et al (1998) Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch 433:49–54

    Article  PubMed  CAS  Google Scholar 

  130. Bohlmeyer T, Le TN, Shroyer AL et al (1998) Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol 18:265–269

    PubMed  CAS  Google Scholar 

  131. Soini Y, Nuorva K, Kamel D et al (1996) Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax 51:887–893

    Article  PubMed  CAS  Google Scholar 

  132. Thomas P, De Lamballerie X, Garbe L et al (1995) Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction. Cell Mol Biol 41:1093–1097

    PubMed  CAS  Google Scholar 

  133. Li Q, Hu K, Pan X et al (1995) Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin Med J (Engl) 108:610–614

    CAS  Google Scholar 

  134. Kinoshita I, Dosaka-Akita H, Shindoh M et al (1995) Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 71:344–349

    Article  PubMed  CAS  Google Scholar 

  135. Szabó I, Sepp R, Nakamoto K et al (1994) Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 73:2740–2744

    Article  PubMed  Google Scholar 

  136. Yousem SA, Ohori NP, Sonmez-Alpan E (1992) Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 69:693–697

    Article  PubMed  CAS  Google Scholar 

  137. Béjui-Thivolet F, Liagre N, Chignol MC et al (1990) Detection of human papillomavirus DNA in squamous bronchial metaplasia and squamous cell carcinomas of the lung by in situ hybridization using biotinylated probes in paraffin-embedded specimens. Hum Pathol 21:111–116

    Article  PubMed  Google Scholar 

  138. Cheng YW, Wu MF, Wang J et al (2007) Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 67:10686–10693

    Article  PubMed  CAS  Google Scholar 

  139. Cheng YW, Wu TC, Chen CY et al (2008) Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis. Clin Cancer Res 14:7173–7179

    Article  PubMed  CAS  Google Scholar 

  140. Hsu NY, Cheng YW, Chan IP et al (2009) Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep 21:81–87

    PubMed  Google Scholar 

  141. Nadji SA, Mahmoodi M, Ziaee AA et al (2007) An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Lung Cancer 56:145–151

    Article  PubMed  Google Scholar 

  142. Buyru N, Altinisik J, Isin M, Dalay N (2008) p53 codon 72 polymorphism and HPV status in lung cancer. Med Sci Monit 14:493–497

    Google Scholar 

  143. Abol-Enein H (2008) Infection: is it a cause of bladder cancer? Scand J Urol Nephrol Suppl 218:79–84

    Article  PubMed  CAS  Google Scholar 

  144. Lopez-Beltran A, Escudero AL (1997) Human papillomavirus and bladder cancer. Biomed Pharmacother 51:252–257

    Article  PubMed  CAS  Google Scholar 

  145. Wiwanitkit V (2005) Urinary bladder carcinoma and human papilloma virus infection, an appraisal of risk. Asian Pac J Cancer Prev 6:217–218

    PubMed  Google Scholar 

  146. Aggarwal S, Arora VK, Gupta S et al (2009) Koilocytosis: correlations with high-risk HPV and its comparison on tissue sections and cytology, urothelial carcinoma. Diagn Cytopathol 37:174–177

    Article  PubMed  Google Scholar 

  147. Badawi H, Ahmed H, Ismail A et al (2008) Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med 10:232

    PubMed  Google Scholar 

  148. Hodges A, Talley L, Gokden N (2006) Human Papillomavirus DNA and P16INK4A are not detected in renal tumors with immunohistochemistry and signal-amplified in situ hybridization in paraffin-embedded tissue. Appl Immunohistochem Mol Morphol 14:432–435

    Article  PubMed  CAS  Google Scholar 

  149. Helal Tel A, Fadel MT, El-Sayed NK (2006) Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors. Pathol Oncol Res 12:173–178

    Article  PubMed  Google Scholar 

  150. Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B (2005) Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis 5:102

    Article  PubMed  CAS  Google Scholar 

  151. Youshya S, Purdie K, Breuer J et al (2005) Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol 58:207–210

    Article  PubMed  CAS  Google Scholar 

  152. Khaled HM, Bahnassi AA, Zekri AR et al (2003) Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol 21:334–341

    Article  PubMed  CAS  Google Scholar 

  153. Fioriti D, Pietropaolo V, Dal Forno S et al (2003) Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 16:283–288

    PubMed  CAS  Google Scholar 

  154. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA (2002) p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179:175–183

    Article  PubMed  CAS  Google Scholar 

  155. Khaled HM, Raafat A, Mokhtar N et al (2001) Human papilloma virus infection and overexpression of p53 protein in bilharzial bladder cancer. Tumori 87:256–261

    PubMed  CAS  Google Scholar 

  156. Westenend PJ, Stoop JA, Hendriks JG (2001) Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder. BJU Int 88:198–201

    Article  PubMed  CAS  Google Scholar 

  157. Sur M, Cooper K, Allard U (2001) Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa. Pathology 33:17–20

    PubMed  CAS  Google Scholar 

  158. Simoneau M, LaRue H, Fradet Y (1999) Low frequency of human papillomavirus infection in initial papillary bladder tumors. Urol Res 27:180–184

    Article  PubMed  CAS  Google Scholar 

  159. De Gaetani C, Ferrari G, Righi E et al (1999) Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation. J Clin Pathol 52:103–106

    Article  PubMed  Google Scholar 

  160. Tekin MI, Tuncer S, Aki FT et al (1999) Human papillomavirus associated with bladder carcinoma? Analysis by polymerase chain reaction. Int J Urol 6:184–186

    Article  PubMed  CAS  Google Scholar 

  161. Gazzaniga P, Vercillo R, Gradilone A et al (1998) Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol 55:262–267

    Article  PubMed  CAS  Google Scholar 

  162. Chan KW, Wong KY, Srivastava G (1997) Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction. J Clin Pathol 50:1018–1021

    Article  PubMed  CAS  Google Scholar 

  163. Aynaud O, Tranbaloc P, Orth G (1998) Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 159:86–89

    Article  PubMed  CAS  Google Scholar 

  164. Lu QL, Lalani E-N, Abel P (1997) Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas. Eur Urol 31:428–432

    PubMed  CAS  Google Scholar 

  165. Boucher NR, Scholefield JH, Anderson JB (1996) The aetiological significance of human papillomavirus in bladder cancer. Br J Urol 78:866–869

    PubMed  CAS  Google Scholar 

  166. López-Beltrán A, Escudero AL, Carrasco-Aznar JC, Vicioso-Recio L (1996) Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. Pathol Res Pract 192:154–159

    PubMed  Google Scholar 

  167. Mvula M, Iwasaka T, Iguchi A et al (1996) Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol 155:471–474

    Article  PubMed  CAS  Google Scholar 

  168. Tenti P, Zappatore R, Romagnoli S et al (1996) p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol 178:65–70

    Article  PubMed  CAS  Google Scholar 

  169. Lopez-Beltran A, Escudero AL, Vicioso L et al (1996) Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 73:124–127

    Article  PubMed  CAS  Google Scholar 

  170. Smetana Z, Keller T, Leventon-Kriss S et al (1995) Presence of human papilloma virus in transitional cell carcinoma in Jewish population in Israel. Cell Mol Biol 41:1017–1023

    PubMed  CAS  Google Scholar 

  171. Kim KH, Kim YS (1995) Analysis of p53 tumor suppressor gene mutations and human papillomavirus infection in human bladder cancers. Yonsei Med J 36:322–331

    PubMed  CAS  Google Scholar 

  172. Gopalkrishna V, Srivastava AN, Hedau S et al (1995) Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction. Genitourin Med 71:231–233

    PubMed  CAS  Google Scholar 

  173. Sano T, Sakurai S, Fukuda T, Nakajima T (1995) Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization. Pathol Int 45:506–512

    Article  PubMed  CAS  Google Scholar 

  174. Lopez-Beltran A, Muñoz E (1995) Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology 26:565–569

    Article  PubMed  CAS  Google Scholar 

  175. Kamel D, Pääkkö P, Pöllänen R et al (1995) Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS 103:331–338

    Article  PubMed  CAS  Google Scholar 

  176. LaRue H, Simoneau M, Fradet Y (1995) Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res 1:435–440

    PubMed  CAS  Google Scholar 

  177. Noel JC, Thiry L, Verhest A et al (1994) Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology 44:671–675

    Article  PubMed  CAS  Google Scholar 

  178. Maloney KE, Wiener JS, Walther PJ (1994) Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. J Urol 151:360–364

    PubMed  CAS  Google Scholar 

  179. Aglianò AM, Gradilone A, Gazzaniga P et al (1994) High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 53:125–129

    Article  PubMed  Google Scholar 

  180. Furihata M, Inoue K, Ohtsuki Y et al (1993) High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53:4823–4827

    PubMed  CAS  Google Scholar 

  181. Saltzstein DR, Orihuela E, Kocurek JN et al (1993) Failure of the polymerase chain reaction (PCR) to detect human papilloma virus (HPV) in transitional cell carcinoma of the bladder. Anticancer Res 13:423–425

    PubMed  CAS  Google Scholar 

  182. Anwar K, Naiki H, Nakakuki K, Inuzuka M (1992) High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70:1967–1973

    Article  PubMed  CAS  Google Scholar 

  183. Shibutani YF, Schoenberg MP, Carpiniello VL, Malloy TR (1992) Human papillomavirus associated with bladder cancer. Urology 40:15–17

    Article  PubMed  CAS  Google Scholar 

  184. Chetsanga C, Malmström PU, Gyllensten U et al (1992) Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer 69:1208–1211

    Article  PubMed  CAS  Google Scholar 

  185. Knowles MA (1992) Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res 20:297–301

    Article  PubMed  CAS  Google Scholar 

  186. Bryant P, Davies P, Wilson D (1991) Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation. Br J Urol 68:49–52

    Article  PubMed  CAS  Google Scholar 

  187. de León DC, Montiel DP, Nemcova J et al (2009) Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer 9:26

    Article  PubMed  CAS  Google Scholar 

  188. Khan NA, Castillo A, Koriyama C et al (2008) Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 99:408–414

    Article  PubMed  CAS  Google Scholar 

  189. Akil N, Yasmeen A, Kassab A et al (2008) High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer 99:404–407

    Article  PubMed  CAS  Google Scholar 

  190. Choi YL, Cho EY, Kim JH et al (2007) Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol 28:327–332

    Article  PubMed  CAS  Google Scholar 

  191. Mendizabal-Ruiz AP, Morales JA, Ramírez-Jirano LJ et al (2009) Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 114:189–194

    Article  PubMed  CAS  Google Scholar 

  192. Grenier J, Soria JC, Mathieu MC et al (2007) Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast. Anticancer Res 27:547–555

    PubMed  Google Scholar 

  193. Gumus M, Yumuk PF, Salepci T et al (2006) HPV DNA frequency and subset analysis in human breast cancer patients’ normal and tumoral tissue samples. J Exp Clin Cancer Res 25:515–521

    PubMed  CAS  Google Scholar 

  194. Lindel K, Forster A, Altermatt HJ et al (2007) Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 16:172–177

    Article  PubMed  Google Scholar 

  195. Kroupis C, Markou A, Vourlidis N et al (2006) Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 39:727–731

    Article  PubMed  CAS  Google Scholar 

  196. Kan CY, Iacopetta BJ, Lawson JS, Whitaker NJ (2005) Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer 93:946–948

    Article  PubMed  CAS  Google Scholar 

  197. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE (2005) Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 7:R1–R11

    Article  PubMed  CAS  Google Scholar 

  198. Tsai JH, Tsai CH, Cheng MH et al (2005) Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 75:276–281

    Article  PubMed  Google Scholar 

  199. Damin AP, Karam R, Zettler CG et al (2004) Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 84:131–137

    Article  PubMed  CAS  Google Scholar 

  200. Liu Y, Klimberg VS, Andrews NR et al (2001) Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 4:329–334

    PubMed  CAS  Google Scholar 

  201. Yu Y, Morimoto T, Sasa M, Okazaki K et al (2000) Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer 7:33–36

    Article  PubMed  CAS  Google Scholar 

  202. de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X, Institut Curie Breast Group (2008) No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 109:55–58

    Article  PubMed  CAS  Google Scholar 

  203. Wrede D, Luqmani YA, Coombes RC, Vousden KH (1992) Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer 65:891–894

    Article  PubMed  CAS  Google Scholar 

  204. Bratthauer GL, Tavassoli FA, O’Leary TJ (1992) Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract 188:384–386

    PubMed  CAS  Google Scholar 

  205. Widschwendter A, Brunhuber T, Wiedemair A et al (2004) Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 31:292–297

    Article  PubMed  CAS  Google Scholar 

  206. Hennig EM, Di Lonardo A, Venuti A, Holm R et al (1999) HPV 16 in multiple neoplastic lesions in women with CIN III. J Exp Clin Cancer Res 18:369–377

    PubMed  CAS  Google Scholar 

  207. Damin DC, Caetano MB, Rosito MA et al (2007) Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 33:569–574

    Article  PubMed  CAS  Google Scholar 

  208. Bodaghi S, Yamanegi K, Xiao SY et al (2005) Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 11:2862–2867

    Article  PubMed  CAS  Google Scholar 

  209. Lu DW, El-Mofty SK, Wang HL (2003) Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol 16:692–699

    Article  PubMed  Google Scholar 

  210. Lee YM, Leu SY, Chiang H et al (2001) Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 34:87–91

    PubMed  CAS  Google Scholar 

  211. McGregor B, Byrne P, Kirgan D et al (1993) Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg 166:738–740

    Article  PubMed  CAS  Google Scholar 

  212. Shah KV, Daniel RW, Simons JW, Vogelstein B (1992) Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol 51:5–7

    Article  PubMed  CAS  Google Scholar 

  213. Kirgan D, Manalo P, McGregor B (1990) Immunohistochemical demonstration of human papilloma virus antigen in human colon neoplasms. J Surg Res 48:397–402

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Virology, School of Medicine, University of Crete, Heraklion, Greece

    Ioannis N. Mammas, George Sourvinos, Apostolos Zaravinos & Demetrios A. Spandidos

Authors
  1. Ioannis N. Mammas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Sourvinos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Apostolos Zaravinos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Demetrios A. Spandidos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Demetrios A. Spandidos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mammas, I.N., Sourvinos, G., Zaravinos, A. et al. Vaccination against Human Papilloma Virus (HPV): Epidemiological Evidence of HPV in Non-genital Cancers. Pathol. Oncol. Res. 17, 103–119 (2011). https://doi.org/10.1007/s12253-010-9288-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-010-9288-0

Keywords

Search

Navigation